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BACKGROUND: Identifying risk factors for acute coronary syndrome (ACS) is important for both diagnostic and prognostic purposes. Abnormal 
platelet parameters, mainly platelet count (PC), mean 
platelet volume (MPV) and platelet distribution width 
(PDW) are thought to be among these risk factors because 
platelet activation plays a pivotal role in ACS. PDW is a 
more specific marker of platelet activation, since it does not 
increase during simple platelet swelling. In this study, the 
comparison of risk factors along with the PDW between 
Non ST-Elevation ACS (NSTEACS) and ST-Elevation ACS 
(STEACS) were investigated.
METHODS: This is a cross-sectional study, patients with 
ACS that admitted at dr.Wahidin Sudirohusodo General 
Hospital Makassar since December 2014 to March 2015 
who undergo coronary angiography were enrolled. All data 
variables  were  taken  according  to  the  medical  record. 
PDW  was  taken  on  first  blood  examination  at  hospital 
admission. Data was significant if p-value <0.05 and was 
processed with SPSS version 16.
RESULTS: A total of 63 patients were enrolled. There were 
significantly higher PDW (p=0.047) in STEACS group 
(13.7±2.0 fL) than in NSTEACS group (12.6±2.3 fL). 
There were a significant positive correlation between PDW 
value and SYNTAX scores (Pearson, r=0.552, p=0.000). 
Cardiovascular risk factors such as history of ACS before 
(p=0.049 & OR=10.216) and dyslipidemia (p=0.049 & 
OR=3.915) along with PDW (p=0.003 & OR=1.733) were 
significant predictor of the incidence of multivessel disease 
in patient with ACS.
CONCLUSION: An increased PDW may predicting more 
severe disease in ACS based on  incidence of STEACS and 
multivessel disease more often and higher SYNTAX score.
KEYWORDS: platelet distribution width, PDW, acute 
coronary syndrome, ACS, multivessel disease, SYNTAX 
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Abstract
Introduction
Cardiovascular diseases (CVD) account for approximately 
12 million deaths annually and are the commonest cause 
of death globally.(1) Ischaemic heart disease (IHD) is 
one of CVD that defined as myocardial impairment due 
to imbalance between coronary blood flow (supply) and 
myocardial requirement (demand). It is divided into stable 
angina secondary to coronary artery disease (CAD) and 
acute coronary syndromes (ACS). ASC is composed of 
patients with acute myocardial infarction with ST-segment 
elevation on their presenting electrocardiogram, ST-
Elevation ACS (STEACS), and those with unstable angina 
and non ST-segment elevation myocardial infarction, or 
non ST-Elevation ACS (NSTEACS).(2) Conventional 
risk factors for atherosclerosis include smoking, diabetes 
mellitus, hypertension, dyslipidemia, obesity and stress 
which either acting singly or in combination increase the 
chances  of  developing  coronary atherosclerosis.  However, 
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Methods
they only explain part of the cases and other relevant risk 
factors need to be identified for an accurate calculation of 
an individual's risk for myocardial infarction.
 Platelet indices such as platelet count (PC), mean 
platelet volume (MPV), and platelet distribution width 
(PDW) have been well utilized for certain conditions 
like idiopathic thrombocytopenic purpura (ITP), aplastic 
anemia and other haemotological and myeloproliferative 
disorders to assess the prognosis but are underutilized 
for cardiovascular disorders.(3) Platelets played a role in 
the pathogenesis of cardiovascular disorders including 
atherosclerosis and its complications such as ACS and 
sudden cardiac death. In ACS there was hyperactivity and 
activation of platelet. Platelet activity is reflected by platelet 
size which is indirectly measured by the some parameters. 
Larger platelets are metabolically and enzymatically more 
active than small platelets.(4) Platelet indices correlate with 
functional status of platelets and is an emerging risk marker 
for atherothrombosis.(5) Platelets with increased number 
and size of pseudopodia differ in size, possibly affecting 
PDW. PDW is a more specific marker of platelet activation, 
since it does not increase during simple platelet swelling.(6) 
 The most sensitive and specific biomarkers of 
myocardial damage are troponin I and troponin T, levels 
of both begin to rise at 2 to 4 hours and peak at 48 hours. 
Creatine Kinase enzymes begins to rise within 2 to 4 hours 
of the onset of myocardial infarction, peaks at about 24 
hours  and  returns  to normal  within approximately 72 
hours.(7) Platelet parameters can be detected earlier than 
markers of myocardial infarction. Platelet indices are 
easily recorded by automated cell counter and are routinely 
available in most clinical laboratories. There is an aim to 
make better use of the platelet parameters generated, as 
patients with larger platelets can easily be identified during 
routine haematologial analysis and could possibly benefit 
from timely treatment.(4) The study was undertaken to 
compare the PDW in STEACS and NSTEACS.
This is a cross-sectional study, which took place at 
Cardiology and Vascular Department, Faculty of Medicine, 
Hasanuddin University/dr.Wahidin Sudirohusodo General 
Hospital Makassar. All data variables based on medical 
record of patients with ACS who admitted at dr.Wahidin 
Sudirohusodo General Hospital Makassar since December 
2014 to March 2015. The inclusion criteria were patients 
more than 18 years who undergo coronary angiography. 
Results
The exclusion criteria were patient with hematology disease 
and bleeding diathesis, patient with end stage renal disease, 
patient with carcinoma, patient with active or chronic 
inflammation, patient with autoimmune disease, patient with 
active infection, patient with blood transfusion, patient with 
cardiomyopathy and patient who didn’t undergo cardiac 
catheterization in any cause. Data of blood examination was 
taken on first blood examination at emergency department 
when admitted to the hospital.
 PDW was taken on first blood examination at hospital 
admission. Patients were divided into two groups: patients 
with STEACS and with NSTEACS. Results were expressed 
as mean±standard deviation. Independent T tests were 
used to compare numerical variables. Chi square tests 
were used to compare categorical variables. Presence of 
multivessel disease and SYNTAX score based on coronary 
angiography. Correlation between continuous variables and 
SYNTAX score were determined by Pearson’s correlation 
test. Predictor of multivessel disease were determined by 
logistic regression test. Data was significant if the p-value 
<0.05 and processed with SPSS version 16.
A total of 63 cases were studied and were divided further into 
two groups, patients with STEACS and with NSTEACS. 
The mean age of patients was 53.46±8.62 years old, with 
range between 35-72 years old. The mean body weight was 
66.62±12.39 kg, with range between 40-96 kg. The mean 
body height was 163.19±5.76 cm, with  range between 143-
175 cm. The mean body mass index was 24.93±4.05 kg/
m2, with range between 16-36.6 kg/m2. The mean waist 
circumference was 92.04±11.39 cm, with  range of 61-119 
cm. The mean systolic blood pressure was 135.71±32.27 
mmHg, with range of 60-230 mmHg. The mean diastolic 
blood pressure was 80.48±21.73 mmHg, with range of 
0-130 mmHg. The mean random blood glucose was 
151.87±78.19 mg/dL, with range of 73-442 mg/dL. The 
mean leukocyte was 11,970±4,891 /mL, with  range of 
5,000-27,000 /mL.The mean PC was 272,000±74,495 /mL, 
with range of 95,000-460,000 /mL. The mean platelecrit was 
0.220±0.06% with range of 0.08-0.36%. The mean MPV 
was 7.88±1.03 fL, with range of 6.3-11 fL. The mean PDW 
was 13.25±2.18 fL, with range of 7.8-17.5 fL. The mean 
total cholesterol was 193.40±47.54 mg/dL, with range of 
108-328 mg/dL. The mean high density lipoprotein (HDL) 
cholesterol was 11.20±33.54 mg/dL, with a range of 9-62 
mg/dL. The mean low density lipoprotein (LDL) cholesterol 
 175
 Platelet Distribution Width in Acute Coronary Syndrome (Mappangara I, et al.)Indones Biomed J. 2016; 8(3): 173-8DOI: 10.18585/inabj.v8i3.219
Table 1. Comparison of categorical variables in STEACS and 
NSTEACS.
was 129.97±45.28 mg/dL, with range of 62-247 mg/dL. The 
mean triglyceride was 168.73±97.49 mg/dL, with range of 
61-643 mg/dL. The mean length of stay was 7.9±4.67 days, 
with range of 1-27 days.
 Total number of males was 56 (88.9%) and number 
of females was 7 (11.1%). The number of males in the 
STEACS group were 35 (62.5%) compared to NSTEACS 
group 21 (37.5%). The numbers of females in the STEACS 
group were 3 (42.85%) compared to NSTEACS group 4 
(57.14%). In our present study, risk factors were evaluated. 
Significantly, more number of patients who had history of 
ACS before and older age were present in NSTEACS than 
STEACS. Other risk factors did not different significantly 
among both of them. There were no difference in the 
incidence of multivessel disease, SYNTAX score group and 
death in hospital between STEACS and NSTEACS. There 
was significantly more number of patients who had heart 
failure in NSTEACS than STEACS (Table 1).
 There was statistically significant different in mean 
ages between STEACS group (51.45 years old) and 
NSTEACS group (56.52 years old) with p=0.021. There 
was statistically significant different in mean leukocyte 
between STEACS group (14.08 years old) and NSTEACS 
group (8.76 years old) with p=0.000. There was statistically 
significant different in mean PDW between STEACS 
group (13.69 years old) and NSTEACS group (12.58 years 
old) with p=0.047. There were not statistically significant 
different in body weight, body height, body mass index, 
waist circumference, systolic blood pressure, diastolic blood 
pressure, random blood glucose, trombocyte, platelecrit, 
MPV, total cholesterol, LDL cholesterol, HDL cholesterol, 
triglyserides, uric acid, number of vessel with significant 
lesion, SYNTAX scores, and length of stay in hospital 
between STEACS group and NSTEACS group (Table 2).
 In  this study, we  also performed Pearson correlation 
test to see platelet indices correlation with SYNTAX score. 
The  results  of  the  analysis  with Pearson correlation 
between the PDW and SYNTAX scores showed a very 
significant positive correlation (Pearson, r=0552, p=0.000); 
while the indices of other platelets and SYNTAX score 
as platelet count (Pearson, r=-0159, p=0214), platelecrit 
(Pearson, r=0.065, p=0612) and MPV (Pearson, r=0185, 
p=0.147) did not  show a significant correlation with 
SYNTAX score. 
 We analyse risk factor along with platelet indices 
and other variables with logistic regression to search factor 
or parameter that can predict the incidence of multivessel 
disease. The mean PDW in the group with multivessel disease 
was 13.9±1.9 fL, while in the group without multivessel 
STEACS NSTEACS
Sex
Male 56 35 21
Female 7 3 4
Family History of CAD
No 51 29 22
Yes 12 9 3
History of ACS 
No 48 35 13
Yes 15 3 12
Hypertension
No 26 18 8
Yes 37 20 17
Diabetes Mellitus
No 52 31 21
Yes 11 7 4
Dyslipidemia
No 31 19 12
Yes 32 19 13
History of Stroke
No 63 38 25
Yes 0 0 0
Smoking
No 15 6 9
Yes 48 32 16
Obesity (BMI>25kg/m2)
No 35 21 14
Yes 28 17 11
Central Obesity
No 28 19 9
Yes 35 19 16
Multivessel Disease
No 22 14 8
Yes 41 24 17
SYNTAX score group
Low (≤22) 40 26 14
Moderate-High (>22) 23 12 11
Presence of Heart Failure
No 30 14 16
Yes 33 24 9
Death in Hospital
No 60 37 23
Yes 3 1 2
*Data was significant if the p -value <0.05
ACS
Risk Factor Total p
0.317
0.248
0.000
0.225
0.804
0.877
-
0.035
0.328
0.065
0.954
0.274
0.693
0.316
disease was 11.9±1.9 fL. Statistical analysis showed that 
PDW mean significantly different with p=0.000. Other 
platelet indices such as platelet count (p=0.649),  platelecrit 
(p=0.446) and MPV (p=0.591) do not have statistically 
significant association with multivessel disease. Other risk 
factors such as history of ACS (p=0.009), dyslipidemia 
(p=0.027) and age (p=0.024) also had significant association 
with multivessel disease (Table 3). 
 Table 4 shows that history of ACS, dyslipidemia, age 
and PDW were analyzed by logistic regression. Statistically 
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SKA Group n mean±SD p
NSTEACS 25 56.52±8.88
STEACS 38 51.45±7.93
Total 63 53.46±5.62
NSTEACS 25 66.36±13.00
STEACS 38 66.79±12.14
Total 63 66.62±12.39
NSTEACS 25 162.48±4.74
STEACS 38 163.66±6.36
Total 63 163.19±5.76
NSTEACS 25 25.09±4.56
STEACS 38 24.83±3.74
Total 63 24.93±4.05
NSTEACS 25 91.84±11.52
STEACS 38 92.17±11.45
Total 63 92.04±11.39
NSTEACS 25 141.6±39.34
STEACS 38 131.84±26.49
Total 63 135.71±32.27
NSTEACS 25 81.2±25.55
STEACS 38 80±19.17
Total 63 80.48±21.73
NSTEACS 25 133.92±45.19
STEACS 38 163.68±92.52
Total 63 151.87±78.20
NSTEACS 25 8.76±2.21
STEACS 38 14.08±5.04
Total 63 11.97±4.89
NSTEACS 25 269.48±65.75
STEACS 38 274.5±80.53
Total 63 272.51±74.50
NSTEACS 25 0.22±0.59
STEACS 38 0.21±0.06
Total 63 0.22±0.06
NSTEACS 25 8.03±1.17
STEACS 38 7.78±0.93
Total 63 7.88±1.03
NSTEACS 25 12.58±2.25
STEACS 38 13.69±2.05
Total 63 13.25±2.18
NSTEACS 25 200.8±48.91
STEACS 38 188.53±46.63
Total 63 193.4±47.54
NSTEACS 25 36.32±9.49
STEACS 38 31.71±11.97
Total 63 33.54±11.20
NSTEACS 25 138.92±48.80
STEACS 38 124.08±42.44
Total 63 129.97±45.28
NSTEACS 25 164.36±94.32
STEACS 38 171.61±100.67
Total 63 168.73±97.49
NSTEACS 25 7.31±2.20
STEACS 38 6.57±2.33
Total 63 6.86±2.29
NSTEACS 25 1.92±1
STEACS 38 1.92±0.88
Total 63 1.92±0.92
NSTEACS 25 16.26±10.43
STEACS 38 15.67±10.60
Total 63 15.91±10.45
NSTEACS 25 7.44±3.32
STEACS 38 8.21±5.4
Total 63 7.9±4.67
0.141
0.021
0.894
0.431
0.801
0.911
0.243
0.832
*Data was significant if the p -value <0.05
Age (years)
Body Weight (kg)
Body Height (cm)
BMI (kg/m2)
Waist Circumference (cm)
Sistolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
Random Blood Glucose (mg/dL)
Leukocyte (103/µL) 0.000
0.796
0.739
0.351
0.047
0.320
Trombocyte (103/µL)
Plateletcrit (%)
MPV (fL)
PDW (fL)
Total Cholesterol (mg/dL)
LDL Cholesterol (mg/dL)
0.111
0.206
Triglyserides (mg/dL)
Uric Acid (mg/dL)
HDL Cholesterol (mg/dL)
SYNTAX Score
Length of Stay in Hospital (days)
0.776
0.212
0.997
0.829
0.526
Number of Vessel with Significant 
Lession
Table 2.  Comparison the mean of numerical variables in STEACS and NSTEACS.
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Yes (n=41) No (n=22)
Sex
Male 36 20
Female 5 2
Family History of CAD
Yes 8 4
No 33 18
History of ACS
Yes 14 1
No 27 21
Hypertension
Yes 25 12
No 16 10
Diabetes Mellitus
Yes 9 2
No 32 20
Dyslipidemia
Yes 25 7
No 16 15
History of Stroke
Yes 0 0
No 41 22
Smoking
Yes 31 17
No 10 5
Obesity (BMI >25 kg/m2)
Yes 17 11
No 24 11
Central Obesity
Yes 24 11
No 17 11
Presence of Heart Failure
Yes 23 10
No 18 12
Death in hospital
Yes 3 0
No 38 22
Age (years) 55.2±8.7 50.1±7.6 0.024
Body Weight (kg) 65.9±13.5 67.8±10.1 0.563
Body Height (cm) 162.9±6.4 163.6±4.5 0.689
BMI (kg/m2) 24.7±4.3 25.3±3.5 0.561
Waist Circumferences (cm) 92.1±12.4 91.8±9.5 0.920
Sistolic Blood Pressure (mmHg) 134.2±29.1 138.6±38.1 0.603
Diastolic Blood Pressure (mmHg) 80.0±20.6 81.4±24.1 0.815
Random Blood Glucose (mg/dL) 153.6±77.7 148.6±80.9 0.812
Leukocyte (103/µL) 11.2±4.4 13.3±6.1 0.104
PC (103/µL) 269.3±74.8 278.4±75.3 0.649
Plateletcrit (%) 0.219±0.06 0.278±0.06 0.446
MPV (fL) 7.9±0.8 7.8±1.4 0.591
PDW (fL) 13.9±1.9 11.9±1.9 0.000
Total Cholestrol (mg/dL) 197.3±52.3 186.1±37.0 0.376
HDL Cholestrol (mg/dL) 32.7±12.5 35.1±8.3 0.412
LDL Cholestrol (mg/dL) 137.5±51.6 116±25.7 0.073
Trygliserides (mg/dL) 161.1±104.6 182.9±83.1 0.402
Uric Acid (mg/dL) 7.2±2.6 6.2±1.3 0.082
Length of stay in Hospital (days) 7.3±3.5 9.1±6.3 0.157
Risk Factor
Multivessel Disease
p
0.194
*Data was significant if the p -value <0.05
0.709
0.898
0.621
0.200
0.027
-
0.883
0.516
0.420
0.516
0.009
Table 3. Comparison between multivessel disease group.
Discussion
Table 4. Logistic regression analysis of history SKA, 
dyslipidemia, age, and PDW with incidence of multivessel 
disease. 
B SE p OR
History of ACS 2.324 1.181 0.049 10.216
Dyslipidemia 1.365 0.693 0.049 3.915
Age 0.041 0.044 0.352 1.042
PDW 0.550 0.186 0.003 1.733
Constant -9.643 3.223 0.003 0.000
*Logistic regression analyze was significant if the p -value <0.05
This study showed that mean PDW value was higher in 
STEACS than NSTEACS. It has been known that STEACS 
was more severe than NSTEACS. Pathophysiologically, 
NSTEACS is somewhat different from STEACS. NSTEACS 
caused by complete occlusion of a minor coronary artery or 
a partial occlusion of a major coronary artery and its causes 
a partial damage of heart muscle. STEACS caused by a 
complete occlusion of a major coronary artery and its causes 
a full damage of heart muscle. Both of them can make some 
complications. But some complications like cardiogenic 
shock, left ventricular failure (like in this study), severe 
mitral regurgitation due to papillary muscle rupture, cardiac 
tamponade due to ventricular wall rupture are more in 
STEACS (due to full thickness heart muscle damage) than 
NSTEACS.
 There were significantly higher leukocytes in STEACS 
than NSTEACS. This result is similar with previous study 
that conclude STEACS patients have significantly higher 
peak CRP levels compared to NSTEACS patients and 
suggest that inflammatory processes play an independent role 
in the pathogenesis of myocardial infarction.(8) There were 
significantly higher PDW in STEACS than NSTEACS. In 
ACS, rupture of unstable plaque activated the thrombogenic 
cascade. However, platelet reactivity plays a vital role in the 
analyse showed that age is no longer a predictor of the 
incidence of multivessel disease with p=0.352; whereas 
history of ACS (p=0.049 & OR=10.216), dyslipidemia 
(p=0.049 & OR=3.915) and PDW (p=0.003 & OR=1.733) 
are a significant predictor of the incidence of multivessel 
disease.
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formation  and  propagation of intracoronary thrombus.(9) 
Other platelet indices such as platelet count, platelecrit, and 
MPV did not significantly different between STEACS and 
NSTEACS. This result similar with study by Vagdatli, et 
al., which conclude that PDW is a more specific marker of 
platelet activation.(6)
 PDW has a positive correlation with SYNTAX 
scores. This result is similar with study by Bekler, et al., 
that conclude PDW is associated with severity of CAD 
based on Gensini score (10) and study by Akin, et al., that 
conclude PDW is a cheap and easy laboratory test which 
independently  associated  with   high  SYNTAX  score (11). 
We also divided patients into multivessel disease group 
and no multivessel group, so we may predict the incidence 
of multivessel disease because it associated with poor 
prognosis.(12) Analyzing the data with logistic regression, 
we found that PDW among with history of ACS before 
and dyslipidemia are statistically significant to predicting 
multivessel disease. We all have known that history of ACS 
before and dyslipidemia are well known cardiovascular 
risk factors that had been proven influence the incidence of 
multivessel disease.
 Limitations of the study include the small sample size 
and only done in one place. The study also did not follow up 
the patient to see that PDW value can be used as a marker of 
future cardiovascular events.
Platelet distribution width in STEACS group is higher than 
in NSTEACS group. The higher PDW, SYNTAX score will 
also be higher. Platelet distribution width is also higher in 
multivessel group. In this study, PDW may be useful to 
predict more severe disease in ACS based on incidence of 
multivessel disease and SYNTAX score.
